cell therapy
BC Cancer Foundation Launches C$6.8M Campaign to Advance CAR T-Cell Therapies
The foundation hopes to put the funds toward two clinical programs in blood cancers and one preclinical project in solid tumors.
In Brief This Week: AstraZeneca, Arrowhead, Immix, Ensoma, Elixirgen, Ideaya Biosciences
News items for the week of Feb. 10, 2025.
FDA Clears Lion TCR to Begin Phase II Trial of TCR T-Cell Therapy in HBV-Related Liver Cancer
The firm will study its autologous cell therapy alone and in combination with Eisai's Lenvima in patients with hepatitis B-driven hepatocellular carcinoma.
Sales of the firm's cell therapy franchise grew modestly in the fourth quarter amid competing product launches and overall slow uptake within the class.
Galapagos Partners With NecstGen to Support Decentralized Cell Therapy Manufacturing
The firm will use NecstGen's cleanroom infrastructure to support manufacturing of its CAR T-cell therapies.
Feb 10, 2025
Mustang Bio Closes $8M Public Offering
Jan 15, 2025
Jan 6, 2025
Dec 30, 2024
Most-Read Precision Medicine Stories in 2024
Dec 30, 2024